• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症的流行病学、诊断和治疗的真实世界数据:基于注册的方法。

Real World Data on the Epidemiology, Diagnosis, and Treatment of Acromegaly: A Registries-based Approach.

机构信息

Endocrine Research Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Endocrine Research Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

出版信息

Arch Med Res. 2023 Sep;54(6):102856. doi: 10.1016/j.arcmed.2023.102856. Epub 2023 Jul 22.

DOI:10.1016/j.arcmed.2023.102856
PMID:37481822
Abstract

INTRODUCTION

Despite the inherent heterogeneity of the information derived from national registries, they are a useful tool to investigate the epidemiological, clinical, biochemical and treatment outcome characteristics of low prevalence conditions such as acromegaly. Although the information provided by single-center experiences is more homogeneous, these studies usually comprise a limited number of patients and thus, frequently lack statistical power.

AREAS COVERED

Registry-based Information regarding the epidemiology, clinical presentation, biochemical and imaging diagnosis, as well as therapeutic outcome and mortality in acromegaly is critically analyzed.

EXPERT OPINION

By gathering data from multiple centers in a specific Country, these registries generate important insights into the real-life behavior of this condition, that should be considered, both, in international consensus meetings and in the design of local, Country-specific diagnostic and therapeutic strategies.

摘要

简介

尽管国家注册中心所提供的信息存在固有的异质性,但它们是一种有用的工具,可以用于研究肢端肥大症等低流行疾病的流行病学、临床、生化和治疗结果特征。虽然单中心经验提供的信息更加同质,但这些研究通常包含有限数量的患者,因此经常缺乏统计学效力。

涵盖领域

对肢端肥大症的流行病学、临床表现、生化和影像学诊断,以及治疗结果和死亡率的基于注册的信息进行了批判性分析。

专家意见

通过在特定国家的多个中心收集数据,这些注册中心深入了解了这种疾病的实际行为,这些信息应该在国际共识会议以及当地、特定国家的诊断和治疗策略的设计中得到考虑。

相似文献

1
Real World Data on the Epidemiology, Diagnosis, and Treatment of Acromegaly: A Registries-based Approach.肢端肥大症的流行病学、诊断和治疗的真实世界数据:基于注册的方法。
Arch Med Res. 2023 Sep;54(6):102856. doi: 10.1016/j.arcmed.2023.102856. Epub 2023 Jul 22.
2
Surgical and Pharmacological Outcomes in Acromegaly: Real-Life Data From the Mexican Acromegaly Registry.肢端肥大症的手术和药物治疗结果:来自墨西哥肢端肥大症登记处的真实数据。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa664.
3
Pharmacological management of acromegaly: a current perspective.肢端肥大症的药物治疗管理:当前视角。
Neurosurg Focus. 2010 Oct;29(4):E14. doi: 10.3171/2010.7.FOCUS10168.
4
[Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].[伴有鞍外扩展的生长激素腺瘤的治疗策略:内科治疗方法的作用,法国肢端肥大症登记处的一项共识研究]
Ann Endocrinol (Paris). 2003 Dec;64(6):434-41.
5
[Current diagnosis and treatment of acromegaly].[肢端肥大症的当前诊断与治疗]
Rev Med Inst Mex Seguro Soc. 2015 Jan-Feb;53(1):74-83.
6
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.垂体生长激素分泌瘤的部分手术切除可增强肢端肥大症患者对生长抑素类似物的反应。
J Clin Endocrinol Metab. 2006 Jan;91(1):85-92. doi: 10.1210/jc.2005-1208. Epub 2005 Nov 1.
7
The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes.墨西哥肢端肥大症登记处:诊断时的临床和生化特征及治疗结果
J Clin Endocrinol Metab. 2016 Nov;101(11):3997-4004. doi: 10.1210/jc.2016-1937. Epub 2016 Jul 18.
8
Acromegaly.肢端肥大症
Pituitary. 2006;9(4):297-303. doi: 10.1007/s11102-006-0409-4.
9
[Therapeutic management of acromegaly].[肢端肥大症的治疗管理]
Med Klin (Munich). 2006 Jan 15;101(1):15-23. doi: 10.1007/s00063-006-1004-1.
10
Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.生长激素抑制素受体配体治疗期间的正常胰岛素样生长因子 1 可预测肢端肥大症的手术治愈。
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa424.

引用本文的文献

1
Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia.生长激素分泌型垂体腺瘤合并高催乳素血症的临床特征及病理特点
J Neurooncol. 2025 Apr 23. doi: 10.1007/s11060-025-05041-w.
2
Long-Term Prognosis and Systemic Impact of Acromegaly: Analyses Utilizing Korean National Health Insurance Data.肢端肥大症的长期预后及全身影响:基于韩国国民健康保险数据的分析
Endocrinol Metab (Seoul). 2025 Feb;40(1):1-9. doi: 10.3803/EnM.2024.2285. Epub 2025 Feb 4.
3
Impact of growth hormone-secreting pituitary adenoma on limbic system and its correlation with cognitive impairment.
生长激素分泌型垂体腺瘤对边缘系统的影响及其与认知障碍的相关性。
Heliyon. 2024 Aug 8;10(16):e35867. doi: 10.1016/j.heliyon.2024.e35867. eCollection 2024 Aug 30.
4
The changing landscape of acromegaly - an epidemiological perspective.肢端肥大症的变化格局——从流行病学角度看。
Rev Endocr Metab Disord. 2024 Aug;25(4):691-705. doi: 10.1007/s11154-024-09875-z. Epub 2024 Feb 10.
5
The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin.生长激素、胰岛素样生长因子-1 和胰岛素之间的迷人相互作用。
Endocrinol Metab (Seoul). 2024 Feb;39(1):83-89. doi: 10.3803/EnM.2024.101. Epub 2024 Jan 9.
6
Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature.聚焦于乳腺生长激素细胞范式的催乳素与生长激素信号传导及相互联系:文献综述
Int J Mol Sci. 2023 Sep 12;24(18):14002. doi: 10.3390/ijms241814002.